These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29427124)

  • 21. [Neuroendocrine tumors of the lung].
    Höfler H
    Verh Dtsch Ges Pathol; 1997; 81():118-24. PubMed ID: 9474862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current knowledge on diagnosis and staging of neuroendocrine tumors.
    Oberg K; Castellano D
    Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():3-7. PubMed ID: 21311954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis.
    Donica H; Malecha-Jędraszek A; Strosławska E; Burska A; Szubstarski F
    Folia Histochem Cytobiol; 2010 Dec; 48(4):603-10. PubMed ID: 21478104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
    Kim SJ; Kim JW; Oh DY; Han SW; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
    Am J Clin Oncol; 2012 Dec; 35(6):549-56. PubMed ID: 21659833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Systemic Therapy for Low-grade Pulmonary Neuroendocrine Tumor].
    Wang Z; Cheng S; Zhou F; Han X; Lu X; Sun D; Zhang X
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):34-39. PubMed ID: 30674391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis, histopathologic grading and prognostic moleculer marker analysis in patients with pancreatic neuroendocrine neoplasm].
    Bao F; Chen GR; Hui P; Cai GP
    Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):426-32. PubMed ID: 24060085
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
    Kim JY; Hong SM
    Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in neuroendocrine tumours of the lung: a single-centre experience.
    Filosso PL; Ruffini E; Di Gangi S; Guerrera F; Bora G; Ciccone G; Galassi C; Solidoro P; Lyberis P; Oliaro A; Sandri A
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):521-6; discussion 526. PubMed ID: 24092506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The new classification of neuroendocrine tumors from the clinical viewpoint].
    Schürmann G; Senninger H
    Z Gastroenterol; 1996 Jun; 34(6):402-3. PubMed ID: 8767831
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
    Özaslan E; Demir S; Karaca H; Güven K
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study.
    Özaslan E; Bayram F; Karaca H; Gürsoy Ş; Öztürk F; Sözüer E; Abdurrezzak Ü; Yurci A; Can Sezgin G; Yıldırım A; Başpınar O; Kula M; Özkan M
    Turk J Gastroenterol; 2016 Nov; 27(6):509-514. PubMed ID: 27852541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible?
    Grillo F; Albertelli M; Annunziata F; Boschetti M; Caff A; Pigozzi S; Ferone D; Mastracci L
    Endocrine; 2016 Jul; 53(1):58-62. PubMed ID: 26362059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.
    Strosberg JR; Weber JM; Feldman M; Coppola D; Meredith K; Kvols LK
    J Clin Oncol; 2013 Feb; 31(4):420-5. PubMed ID: 23248248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrum of pulmonary neuroendocrine proliferations and neoplasms.
    Benson RE; Rosado-de-Christenson ML; Martínez-Jiménez S; Kunin JR; Pettavel PP
    Radiographics; 2013 Oct; 33(6):1631-49. PubMed ID: 24108555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine neoplasms of the lung: Concepts and terminology.
    Wick MR; Marchevsky AM
    Semin Diagn Pathol; 2015 Nov; 32(6):445-55. PubMed ID: 26500079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchopulmonary neuroendocrine tumors.
    Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
    Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
    Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New data in the classification of pulmonary neuroendocrine proliferation].
    Lantuejoul S; Brambilla E
    Ann Pathol; 2000; 20 Suppl():S131-4. PubMed ID: 11261291
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.